Chris Schott
Stock Analyst at J.P. Morgan
(4.39)
# 1,294
Out of 4,696 analysts
662
Total ratings
59%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Chris Schott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,400 | $1,160.08 | +20.68% | 73 | Sep 2, 2026 | |
| AMRX Amneal Pharmaceuticals | Maintained: Buy | $18 → $22 | $18.06 | +21.82% | 20 | Aug 26, 2026 | |
| MRK Merck & Co. | Maintained: Buy | n/a | $151.64 | - | 36 | Aug 19, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | n/a | $24.68 | - | 23 | Aug 11, 2026 | |
| VTRS Viatris | Maintained: Hold | $18 | $17.09 | +5.32% | 29 | Aug 10, 2026 | |
| ZTS Zoetis | Maintained: Buy | $130 → $115 | $76.17 | +50.98% | 16 | Aug 10, 2026 | |
| RPRX Royalty Pharma | Maintained: Buy | $58 → $62 | $63.11 | -1.76% | 10 | Aug 10, 2026 | |
| AMGN Amgen | Maintained: Hold | $300 → $350 | $442.84 | -20.96% | 12 | Aug 6, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $160 | $149.61 | +6.94% | 34 | Aug 6, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $73 | $67.66 | +7.89% | 42 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $29.02 | -3.51% | 90 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $850 → $900 | $852.03 | +5.63% | 32 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $185 → $210 | $222.67 | -5.69% | 20 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $260 → $270 | $275.21 | -1.89% | 20 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $280 | $261.72 | +6.98% | 38 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $37.49 | - | 43 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $15 | $14.49 | +3.52% | 31 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $12 → $11 | $13.77 | -20.12% | 13 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $675 → $775 | $538.99 | +43.79% | 15 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $8 | $1.42 | n/a | 9 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.46 | n/a | 41 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.26 | n/a | 3 | May 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €82.85 → €84.58 | €139.65 | n/a | 2 | Mar 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 → $54 | $26.58 | n/a | 4 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | May 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $0.5225 | n/a | 3 | Nov 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.70 | n/a | 1 | Oct 17, 2013 |
Eli Lilly and Company
Sep 2, 2026
Maintained: Buy
Price Target: $1,400
Current: $1,160.08
Upside: +20.68%
Amneal Pharmaceuticals
Aug 26, 2026
Maintained: Buy
Price Target: $18 → $22
Current: $18.06
Upside: +21.82%
Merck & Co.
Aug 19, 2026
Maintained: Buy
Price Target: n/a
Current: $151.64
Upside: -
Elanco Animal Health
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $24.68
Upside: -
Viatris
Aug 10, 2026
Maintained: Hold
Price Target: $18
Current: $17.09
Upside: +5.32%
Zoetis
Aug 10, 2026
Maintained: Buy
Price Target: $130 → $115
Current: $76.17
Upside: +50.98%
Royalty Pharma
Aug 10, 2026
Maintained: Buy
Price Target: $58 → $62
Current: $63.11
Upside: -1.76%
Amgen
Aug 6, 2026
Maintained: Hold
Price Target: $300 → $350
Current: $442.84
Upside: -20.96%
Gilead Sciences
Aug 6, 2026
Maintained: Buy
Price Target: $160
Current: $149.61
Upside: +6.94%
Bristol-Myers Squibb Company
Aug 4, 2026
Maintained: Buy
Price Target: $73
Current: $67.66
Upside: +7.89%
Aug 4, 2026
Maintained: Hold
Price Target: $28
Current: $29.02
Upside: -3.51%
Aug 4, 2026
Maintained: Buy
Price Target: $850 → $900
Current: $852.03
Upside: +5.63%
Jul 30, 2026
Maintained: Hold
Price Target: $185 → $210
Current: $222.67
Upside: -5.69%
Jul 16, 2026
Rated: Hold
Price Target: $260 → $270
Current: $275.21
Upside: -1.89%
Jul 9, 2026
Rated: Buy
Price Target: $280
Current: $261.72
Upside: +6.98%
Jun 15, 2026
Maintained: Buy
Price Target: n/a
Current: $37.49
Upside: -
Feb 27, 2026
Maintained: Hold
Price Target: $18 → $15
Current: $14.49
Upside: +3.52%
Feb 13, 2026
Maintained: Sell
Price Target: $12 → $11
Current: $13.77
Upside: -20.12%
Nov 3, 2025
Maintained: Buy
Price Target: $675 → $775
Current: $538.99
Upside: +43.79%
May 25, 2023
Maintained: Hold
Price Target: $9 → $8
Current: $1.42
Upside: n/a
Jul 28, 2022
Downgraded: Hold
Price Target: n/a
Current: $9.46
Upside: n/a
May 19, 2020
Downgraded: Hold
Price Target: n/a
Current: $2.26
Upside: n/a
Mar 9, 2020
Maintained: Buy
Price Target: €82.85 → €84.58
Current: €139.65
Upside: n/a
Feb 20, 2020
Maintained: Hold
Price Target: $43 → $54
Current: $26.58
Upside: n/a
May 13, 2019
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 17, 2017
Maintained: Buy
Price Target: $35
Current: $0.5225
Upside: n/a
Oct 17, 2013
Downgraded: Hold
Price Target: n/a
Current: $13.70
Upside: n/a